ITI Pharma and Healthcare Fund
Direct Plan · Growth Option · Sectoral / Thematic · Scheme code 149268
Returns (%)
| 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y | Launch | |
|---|---|---|---|---|---|---|---|---|---|
| This scheme | 2.09 | 11.26 | 19.22 | 16.39 | 20.99 | — | — | — | 15.67 |
| Nifty 500 benchmark |
0.87 | 4.31 | 2.15 | 5.20 | 12.49 | 11.41 | — | — | 15.49 |
| Sectoral / Thematic category median |
— | — | — | -5.63 | 13.04 | 10.23 | — | 13.74 | — |
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.
Risk
| Volatility | Sharpe | Sortino | Beta | Alpha | Max fall | R² | |
|---|---|---|---|---|---|---|---|
| This scheme | 16.4% | 0.88 | 1.45 | 0.80 | 9.63% | -17.7% | 55.33 |
| Nifty 500 benchmark |
15.2% | 0.39 | 0.58 | — | — | -37.3% | — |
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
| Windows | Worst | Median | Best | Periods that lost money |
|---|---|---|---|---|
| 936 | -9.3% | 16.4% | 61.9% | 23% |
Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
| Up capture | Down capture | Correlation | Tracking error | Information ratio | Treynor |
|---|---|---|---|---|---|
| 114% | 73% | 0.74 | 11.4% | 0.74 | 17.90 |
Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 36 months this scheme and Nifty 500 share.